&nbsp;

FNIM_introduction.jpg

Dec 2017

Regimen

FLAG

Cancer Type:

Hematologic,

Leukemia - Acute Lymphoblastic (ALL),

Leukemia - Acute Myeloid (AML)

Intent: Palliative

Drugs Used:

fludarabine,

cytarabine

Quick Link(s):

Regimen Monograph

May 2019

Document

2018 CSRT CoP Annual Report

Aug 2018

Regimen

FC+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

Drugs Used:

Quick Link(s):

Regimen Monograph

Jun 2021

Regimen

FC(PO)+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

ODB - General Benefit

cyclophosphamide - oral tablets

Drugs Used:

fludarabine (Unfunded),

cyclophosphamide

Quick Link(s):

Regimen Monograph

May 2019

Regimen

FCM(PO)+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

ODB - General Benefit

cyclophosphamide - oral tablets

Drugs Used:

mitoXANTRONE,

fludarabine (Unfunded),

cyclophosphamide

Quick Link(s):

Regimen Monograph

May 2019

Regimen

FCM+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

Drugs Used:

Quick Link(s):

Regimen Monograph

Jun 2021

Regimen

FLUD+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

Drugs Used:

fludarabine

Quick Link(s):

Regimen Monograph

Jun 2021

Regimen

FLUD(PO)+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

Drugs Used:

fludarabine (Unfunded)

Quick Link(s):

Regimen Monograph

May 2019

Regimen

FOLFIRI

Cancer Type:

Gastrointestinal,

Neuroendocrine (GI)

Intent: Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2023

Document

Fever.PNG

Mar 2019

Document